TRIP13 Pan-Cancer Multi-Omics Analysis Supporting Oncogenic Role

A pan-cancer multi-omics analysis from figshare investigates the oncogenic role of the TRIP13 gene. The dataset, authored by Yuanqiao Zhao and last updated in April 2026, likely contains expression data, prognostic associations, and immune infiltration correlations across various cancer types. It is a 12.1 MB PDF file licensed under CC-BY-4.0.

Use Cases

• Identifying TRIP13 as a prognostic biomarker based on its pan-cancer expression analysis.
• Investigating the association between TRIP13 expression and tumor immune cell infiltration.
• Analyzing the correlation of TRIP13 with tumor mutational burden (TMB) and microsatellite instability (MSI).
• Exploring the E2F1–TRIP13–HECTD3 regulatory axis in prostate cancer drug resistance.

Strengths

• Analysis integrates multi-omics data from publicly available resources for a pan-cancer perspective.
• Includes functional validation from in vitro experiments mentioned in the description.
• Released under a permissive CC-BY-4.0 license for reuse.

Limitations

• Dataset is a 12.1 MB PDF; the underlying structured data is not directly accessible.
• Column-level documentation and sample data are unavailable, requiring manual extraction.
• Row count and specific data formats for the original analyses are unknown.

Provenance

Source

figshare

Collection Method

Systematic analysis of pan-cancer multi-omics data from publicly available resources.

Time Range

null

Freshness

Last updated 2026-04-22 05:35:22; freshness should be verified.

Geography

null